4.2
Kronik Obstrüktif Akciğer Hastalığı II: Patofizyoloji
Kronik Obstrüktif Akciğer Hastalığı (KOAH) patofizyolojisi karmaşık ve çok yönlüdür ve fizyolojik süreçlerin karmaşık bir etkileşimini içerir. Bu meka…
Kronik obstrüktif akciğer hastalığı veya KOAH, öncelikle sigara dumanı, toz veya hava kirliliği gibi tahriş edici maddelere maruz kalmaya bağlı kronik hava yolu iltihabından kaynaklanır.
Lenfositler, makrofajlar ve nötrofiller dahil olmak üzere enflamatuar hücreler, hava yolu duvarını istila ederek lökotrienler ve sitokinler gibi zararlı mediatörleri serbest bırakır.
Bu enflamatuar hücreler tarafından üretilen solunan partiküller ve oksidanlar iltihabı şiddetlendirir.
Oksidanlar, akciğer dokusunun bozulmasına karşı koruma sağlayan antiproteaz bileşiklerini inhibe eder.
Aynı zamanda, akciğer dokusunu bozan proteaz enzimlerinin aktivitesini arttırırlar.
Bu dengesizlik, proteazlar ve antiproteazlar arasındaki doğal dengeyi bozarak alveollerin bozulmasına ve akciğer elastikiyetinin kaybına yol açar.
Sonuç olarak, hava yolları daralır, hava akışını engeller, bu da aşırı mukus üretimini teşvik eder ve akciğerlerde sıvı birikmesine neden olur.
KOAH'ta kronik inflamasyon oksidatif strese neden olur, akciğer dokusuna zarar veren serbest radikalleri serbest bırakır, bül oluşumuna ve alveol duvarının bozulmasına yol açarak gaz alışverişini bozar.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic airway inflammation in COPD?
COPD develops from chronic exposure to irritants like cigarette smoke, dust, and air pollution. These irritants trigger inflammatory cells—lymphocytes, macrophages, and neutrophils—to infiltrate airway walls and release harmful mediators such as leukotrienes and cytokines. This perpetuates ongoing inflammation and progressive lung damage characteristic of the disease.
Q2: How does the protease-antiprotease imbalance damage lung tissue in COPD?
Oxidants from cigarette smoke impair antiproteases like alpha-1 antitrypsin that normally protect lung tissue. Simultaneously, oxidants increase protease activity, particularly elastase, which degrades extracellular matrix components. This imbalance causes destruction of alveolar walls and lung parenchyma, leading to emphysema and loss of lung elasticity.
Q3: What role do free radicals play in COPD pathophysiology?
Chronic inflammation generates reactive oxygen species (ROS) like superoxide anions and hydroxyl radicals from cigarette smoke and inflammatory cells. These free radicals damage cellular structures, proteins, lipids, and DNA, further promoting inflammation and lung tissue deterioration. This oxidative stress perpetuates the cycle of tissue destruction in COPD.
Q4: How does airway narrowing occur in COPD?
Chronic inflammation causes structural changes and constriction in airways, reducing airflow. Mucus hypersecretion and mucosal edema exacerbate narrowing, while smooth muscle constriction further impedes airflow. Additionally, increased vascular permeability from inflammation leads to fluid accumulation in lungs, contributing to obstruction and airway blockage.
Q5: What structural changes occur in the lungs during COPD?
Ongoing tissue destruction causes alveolar enlargement and bullae formation—large air pockets within lung tissue. Destruction of alveolar walls reduces surface area for gas exchange, impairing oxygen uptake and carbon dioxide elimination. These structural changes decrease lung compliance and elasticity, leading to reduced oxygen uptake and shortness of breath.
Q6: How do inflammatory mediators perpetuate lung damage in COPD?
Inflammatory cells release cytokines, leukotrienes, and other mediators that perpetuate the inflammatory response. These mediators recruit additional inflammatory cells and sustain the release of proteases and oxidants. This creates a self-perpetuating cycle of inflammation and tissue destruction that characterizes COPD progression.
Q7: Why is gas exchange impaired in COPD?
Destruction of alveolar walls reduces the surface area available for oxygen and carbon dioxide exchange. Combined with fluid accumulation and airway obstruction, these structural changes impair gas exchange efficiency. Understanding these mechanisms is essential for developing effective chronic obstructive pulmonary disease management strategies.